Cargando…

Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients with Schizophrenia

BACKGROUND: Visual learning plays an important role in general populations and patients with schizophrenia. Genetic influences on visual learning remain unknown. Two functional single nucleotide polymorphisms (SNPs), Ser704Cys of the DISC1 gene and M24 (rs1421292) of the G72 gene, are strongly assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Jane Pei-Chen, Huang, Kuo-Hao, Lin, Chieh-Hsin, Lane, Hsien-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096242/ https://www.ncbi.nlm.nih.gov/pubmed/32256073 http://dx.doi.org/10.2147/NDT.S235675

Ejemplares similares

Combination of G72 Genetic Variation and G72 Protein Level to Detect Schizophrenia: Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2018)

Investigation of G72 (DAOA) expression in the human brain
por: Benzel, Isabel, et al.
Publicado: (2008)

Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia
por: Bass, Nicholas J, et al.
Publicado: (2009)

Adaptive evolution and elucidating the potential inhibitor against schizophrenia to target DAOA (G72) isoforms
por: Sehgal, Sheikh Arslan, et al.
Publicado: (2015)

Pharmacoinformatics, Adaptive Evolution, and Elucidation of Six Novel Compounds for Schizophrenia Treatment by Targeting DAOA (G72) Isoforms
por: Sehgal, Sheikh Arslan
Publicado: (2017)

DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis
por: Mössner, Rainald, et al.
Publicado: (2009)

Effect of the G72 (DAOA) putative risk haplotype on cognitive functions in healthy subjects
por: Jansen, Andreas, et al.
Publicado: (2009)

d-Amino Acids and pLG72 in Alzheimer’s Disease and Schizophrenia
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

S171. EFFECT OF DAOA GENETIC VARIATION ON WHITE MATTER ALTERATION IN CORPUS CALLOSUM IN PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA
por: Su, Wenjun, et al.
Publicado: (2020)

Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection
por: Lin, Eugene, et al.
Publicado: (2021)

Expression of D-Amino Acid Oxidase (DAO/DAAO) and D-Amino Acid Oxidase Activator (DAOA/G72) during Development and Aging in the Human Post-mortem Brain
por: Jagannath, Vinita, et al.
Publicado: (2017)

Genetic Variations of DAOA (rs947267 and rs3918342) and COMT Genes (rs165599 and rs4680) in Schizophrenia and Bipolar I Disorder
por: Ahmadi, Leila, et al.
Publicado: (2018)

Structural, phylogenetic and docking studies of D-amino acid oxidase activator (DAOA), a candidate schizophrenia gene
por: Sehgal, Sheikh Arslan, et al.
Publicado: (2013)

Diagnosing Alzheimer’s Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers
por: Lane, Hsien-Yuan, et al.
Publicado: (2022)

PICK1 Genetic Variation and Cognitive Function in Patients with Schizophrenia
por: Chen, Yi-Ting, et al.
Publicado: (2017)

The DAOA/G30 locus and affective disorders: haplotype based association study in a polydiagnostic approach
por: Gawlik, Micha, et al.
Publicado: (2010)

Gene Polymorphisms and Expression of NRG1, DAOA, and DISC1 Genes in a Chinese Han Population with an Ultra-High Risk for Psychosis
por: He, Xiao-Yan, et al.
Publicado: (2023)

Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions
por: Lin, Eugene, et al.
Publicado: (2021)

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis
por: Bousman, C A, et al.
Publicado: (2013)

pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Cognitive Manic Symptoms in Bipolar Disorder Associated with Polymorphisms in the DAOA and COMT Genes
por: Hukic, Dzana Sudic, et al.
Publicado: (2013)

Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
por: Hung, Chung-Chieh, et al.
Publicado: (2021)

The C-Terminal Region of G72 Increases d-Amino Acid Oxidase Activity
por: Chang, Sunny Li-Yun, et al.
Publicado: (2013)

Association of a Nonsynonymous Variant of DAOA with Visuospatial Ability in a Bipolar Family Sample
por: Soronen, Pia, et al.
Publicado: (2008)

Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences
por: Chen, Chien-Yu, et al.
Publicado: (2016)

Prediction Analysis for Transition to Schizophrenia in Individuals at Clinical High Risk for Psychosis: The Relationship of DAO, DAOA, and NRG1 Variants with Negative Symptoms and Cognitive Deficits
por: Jagannath, Vinita, et al.
Publicado: (2017)

Allelic frequency differences of DAOA variants between Caucasians and Asians and their association with major mood disorders
por: Yang, Zhihua, et al.
Publicado: (2019)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes
por: Sacchetti, Emilio, et al.
Publicado: (2013)

Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments
por: Lin, Eugene, et al.
Publicado: (2021)

Controversial Effects of D-Amino Acid Oxidase Activator (DAOA)/G72 on D-Amino Acid Oxidase (DAO) Activity in Human Neuronal, Astrocyte and Kidney Cell Lines: The N-methyl D-aspartate (NMDA) Receptor Hypofunction Point of View
por: Jagannath, Vinita, et al.
Publicado: (2017)

PM405. Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2016)

An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
por: Lin, Eugene, et al.
Publicado: (2020)

Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer's Disease
por: Vélez, Jorge I., et al.
Publicado: (2016)

Genetic Biomarkers on Age-Related Cognitive Decline
por: Lin, Chieh-Hsin, et al.
Publicado: (2017)

Deep Learning with Neuroimaging and Genomics in Alzheimer’s Disease
por: Lin, Eugene, et al.
Publicado: (2021)

Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_herbqub9l3r8pep85l9o2md1cn